POSTERIOR SUB-TENON'S Avastin
- Sponsor
- Asociación para Evitar la Ceguera en México
- Study ID
- NCT00567372
- Phase
- PHASE4
- Status
- Withdrawn
Conditions
- Diffuse Diabetic Macular Edema
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- bevacizumab (Sub-tenon´s injection) — DRUGa single posterior sub-tenon's capsule injection of bevacizumab (2.5 mg /0.1ml)
Study Details
Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema
Key Dates
- First listed
- Dec 4, 2007
- Start date
- Jun 30, 2008
- Status verified
- May 2024
- Primary completion
- Nov 30, 2008
- Completion
- Jun 30, 2009
Study Design
- Enrollment
- 0 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Primary Outcome Measure
macular volume [ Time Frame: baseline, 3,6 and 12 weeks ]